|
🐜
|
Heterogeneity of genomic evolution and mutational profiles in multiple myeloma
35 auth.
N. Bolli,
H. Avet-Loiseau,
D. Wedge,
P. Van Loo,
L. Alexandrov,
I. Martincorena,
K. Dawson,
F. Iorio,
S. Nik-Zainal,
G. Bignell,
Jonathan Hinton,
Yilong Li,
J. Tubío,
Stuart Mclaren,
Sarah O 'meara,
...
Adam P. Butler,
J. Teague,
L. Mudie,
Elizabeth Anderson,
N. Rashid,
Y. Tai,
M. Shammas,
A. Sperling,
M. Fulciniti,
P. Richardson,
G. Parmigiani,
F. Magrangeas,
S. Minvielle,
P. Moreau,
M. Attal,
T. Facon,
P. Futreal,
K. Anderson,
Peter J. Campbell,
Nikhil C. Munshi
|
9 |
2014 |
9
🐜
|
|
🦁
|
Anti-DKK1 mAb (BHQ880) as a potential therapeutic agent for multiple myeloma.
16 auth.
M. Fulciniti,
P. Tassone,
T. Hideshima,
S. Vallet,
P. Nanjappa,
S. Ettenberg,
Zhenxin Shen,
Nipun Patel,
Y. Tai,
D. Chauhan,
...
C. Mitsiades,
R. Prabhala,
N. Raje,
K. Anderson,
D. Stover,
N. Munshi
|
8 |
2007 |
8
🦁
|
|
🐜
|
Blockade of XBP1 splicing by inhibition of IRE1α is a promising therapeutic option in multiple myeloma.
25 auth.
N. Mimura,
M. Fulciniti,
G. Gorgun,
Y. Tai,
D. Cirstea,
L. Santo,
Yiguo Hu,
C. Fabre,
J. Minami,
H. Ohguchi,
T. Kiziltepe,
H. Ikeda,
Y. Kawano,
Maureen French,
M. Blumenthal,
...
Victor L Tam,
N. Kertesz,
U. Malyankar,
M. Hokenson,
T. Pham,
Qingping Zeng,
J. Patterson,
P. Richardson,
N. Munshi,
K. Anderson
|
8 |
2011 |
8
🐜
|
|
🐜
|
Identification of novel mutational drivers reveals oncogene dependencies in multiple myeloma.
39 auth.
B. Walker,
K. Mavrommatis,
C. Wardell,
T. C. Ashby,
M. Bauer,
F. Davies,
A. Rosenthal,
Hongwei Wang,
P. Qu,
A. Hoering,
M. Samur,
F. Towfic,
M. Ortiz,
E. Flynt,
Zhinuan Yu,
...
Zhihong Yang,
Daniel K. Rozelle,
J. Obenauer,
M. Trotter,
D. Auclair,
J. Keats,
N. Bolli,
M. Fulciniti,
R. Szalat,
P. Moreau,
B. Durie,
A. Stewart,
H. Goldschmidt,
M. Raab,
H. Einsele,
P. Sonneveld,
J. San Miguel,
S. Lonial,
G. Jackson,
K. Anderson,
H. Avet-Loiseau,
N. Munshi,
A. Thakurta,
G. Morgan
|
8 |
2018 |
8
🐜
|
|
🐜
|
A high-risk, Double-Hit, group of newly diagnosed myeloma identified by genomic analysis
39 auth.
B. Walker,
K. Mavrommatis,
C. Wardell,
T. C. Ashby,
M. Bauer,
F. Davies,
A. Rosenthal,
Hongwei Wang,
P. Qu,
A. Hoering,
M. Samur,
F. Towfic,
M. Ortiz,
E. Flynt,
Zhinuan Yu,
...
Zhihong Yang,
Daniel K. Rozelle,
J. Obenauer,
M. Trotter,
D. Auclair,
J. Keats,
N. Bolli,
M. Fulciniti,
R. Szalat,
P. Moreau,
B. Durie,
A. Stewart,
H. Goldschmidt,
M. Raab,
H. Einsele,
P. Sonneveld,
J. San Miguel,
S. Lonial,
G. Jackson,
K. Anderson,
H. Avet-Loiseau,
N. Munshi,
A. Thakurta,
G. Morgan
|
8 |
2018 |
8
🐜
|
|
🐜
|
Elevated IL-17 produced by TH17 cells promotes myeloma cell growth and inhibits immune function in multiple myeloma.
16 auth.
R. Prabhala,
Dheeraj Pelluru,
M. Fulciniti,
Harsha K. Prabhala,
P. Nanjappa,
Weihua Song,
Christine Pai,
S. Amin,
Y. Tai,
P. Richardson,
...
I. Ghobrial,
S. Treon,
J. Daley,
K. Anderson,
J. Kutok,
N. Munshi
|
8 |
2010 |
8
🐜
|
|
🐜
|
HLA class I, NKG2D, and natural cytotoxicity receptors regulate multiple myeloma cell recognition by natural killer cells.
14 auth.
E. Carbone,
P. Neri,
M. Mesuraca,
M. Fulciniti,
T. Otsuki,
D. Pende,
V. Groh,
T. Spies,
G. Pollio,
D. Cosman,
...
L. Catalano,
P. Tassone,
B. Rotoli,
S. Venuta
|
8 |
2005 |
8
🐜
|
|
🐜
|
Pharmacologic targeting of a stem/progenitor population in vivo is associated with enhanced bone regeneration in mice.
21 auth.
S. Mukherjee,
N. Raje,
Jesse A. Schoonmaker,
Julie C. Liu,
T. Hideshima,
Marc N. Wein,
Dallas Jones,
S. Vallet,
M. Bouxsein,
S. Pozzi,
...
S. Chhetri,
Y. D. Seo,
J. Aronson,
C. Patel,
M. Fulciniti,
L. Purton,
L. Glimcher,
J. Lian,
G. Stein,
K. Anderson,
D. Scadden
|
7 |
2008 |
7
🐜
|
|
🐜
|
Targeted Disruption of the BCL9/β-Catenin Complex Inhibits Oncogenic Wnt Signaling
17 auth.
K. Takada,
Di Zhu,
Gregory H. Bird,
K. Sukhdeo,
Jian-jun Zhao,
M. Mani,
M. Lemieux,
D. Carrasco,
J. Ryan,
D. Horst,
...
M. Fulciniti,
N. Munshi,
Wenqing Xu,
A. Kung,
R. Shivdasani,
L. Walensky,
D. Carrasco
|
7 |
2012 |
7
🐜
|
|
🐜
|
Biallelic loss of BCMA as a resistance mechanism to CAR T cell therapy in a patient with multiple myeloma
15 auth.
M. Samur,
M. Fulciniti,
Anil Aktas Samur,
A. Bazarbachi,
Y. Tai,
R. Prabhala,
A. Alonso,
A. Sperling,
T. Campbell,
F. Petrocca,
...
K. Hege,
S. Kaiser,
H. A. Loiseau,
K. Anderson,
N. Munshi
|
7 |
2021 |
7
🐜
|
|
🐜
|
Triplet Therapy, Transplantation, and Maintenance until Progression in Myeloma.
56 auth.
P. Richardson,
S. Jacobus,
E. Weller,
H. Hassoun,
S. Lonial,
N. Raje,
E. Medvedova,
P. McCarthy,
E. Libby,
P. Voorhees,
R. Orlowski,
L. Anderson,
J. Zonder,
C. Milner,
C. Gasparetto,
...
M. Agha,
A. Khan,
D. Hurd,
K. Gowin,
R. Kamble,
S. Jagannath,
N. Nathwani,
M. Alsina,
R. Cornell,
Hamza Hashmi,
E. Campagnaro,
Astrid C. M. Andreescu,
T. Gentile,
M. Liedtke,
Kelly Godby,
A. Cohen,
T. Openshaw,
M. Pasquini,
S. Giralt,
J. Kaufman,
A. Yee,
E. Scott,
P. Torka,
A. Foley,
M. Fulciniti,
K. Hebert,
M. Samur,
Kelly Masone,
Michelle E. Maglio,
Andrea A. Zeytoonjian,
Omar Nadeem,
R. Schlossman,
J. Laubach,
Claudia E. Paba-Prada,
I. Ghobrial,
A. Perrot,
P. Moreau,
H. Avet-Loiseau,
M. Attal,
K. Anderson,
N. Munshi
|
7 |
2022 |
7
🐜
|
|
🐜
|
Activin A promotes multiple myeloma-induced osteolysis and is a promising target for myeloma bone disease
23 auth.
S. Vallet,
S. Mukherjee,
N. Vaghela,
T. Hideshima,
M. Fulciniti,
S. Pozzi,
L. Santo,
D. Cirstea,
K. Patel,
A. Sohani,
...
Alex Guimaraes,
W. Xie,
D. Chauhan,
Jesse A. Schoonmaker,
E. Attar,
Michael Churchill,
E. Weller,
N. Munshi,
J. Seehra,
R. Weissleder,
K. Anderson,
D. Scadden,
N. Raje
|
7 |
2010 |
7
🐜
|
